Report cover image

Global Generic Drugs Market

Publisher QualiKet Research
Published Feb 04, 2022
Length 176 Pages
SKU # QUA17148668

Description

Global Generic Drugs Market

Global Generic Drugs Market Size, Trends & Growth Opportunity, By Product Type (Simple Generics, Super Generics, and Biosimilars), By Application (Anti-infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Respiratory Products, Anti-Cancer Drugs, and Others), By Distribution Channel (Pharmacies, Private Clinics, Drug Stores, Hospitals, Retail Pharmacies, and Others), By Region and Forecast till 2027

Global Generic Drugs Market

The generic drugs are defined as the medications which have the same active ingredient as that of branded drugs. They also yield the same therapeutic effect and are prescribed in the same dosing. The inactive ingredients are differ as compared to their branded counter parts. Generic drugs are mainly marketed after a patent expiry of the branded drug. These drugs are of equivalent quality as compared to the branded drugs & are manufactured under the same safety and manufacturing procedures.

Market Drivers

The growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases etc., which expected to boost the global generic drugs market growth over the forecast period. The generic drugs are cheaper & equivalent to barded drugs in strength, dosage, route of administration, performance, quality, and application. Also, the increase in geriatric population positively influence the global generic drugs market growth during this forecast period. Furthermore, the increase in healthcare expenditure expected to fuel the market growth. Moreover, huge demand for generic medicine as well as a large number of patents expired branded drugs will propel the global generic drugs market growth. In addition, the growing demand for newer versions of generic drugs, and large numbers of licensing & partnering strategies to launch new products by key vendors will support the market growth in near future.

Market Restraints

Stringent governmental regulations and adverse effects associated with drugs are anticipated to hamper the global generic drugs market during this forecast timeframe.

Market Segmentation

The Global generic Drugs Market is segmented into product type such as Simple Generics, Super Generics, and Biosimilars, by application such as Anti-infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Respiratory Products, Anti-Cancer Drugs, and Others. Further, market is segmented into distribution channel such as Pharmacies, Private Clinics, Drug Stores, Hospitals, Retail Pharmacies, and Others.

Also, the Global Generic Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as Abbott Laboratories, GlaxoSmithKline Plc., Eli Lilly and Company, Pfizer Inc, STADA Arzneimittel AG, Teva Pharmaceutical, Mylan N.V., Sandoz International, Baxter International, ALLERGAN, etc.

Market Taxonomy

By Product Type
  • Simple Generics
  • Super Generics
  • Biosimilars
By Application
  • Anti-infective Drugs
  • Anti-Arthritis Drugs
  • Central Nervous System Drugs
  • Respiratory Products
  • Anti-Cancer Drugs
  • Others
By Distribution Channel
  • Pharmacies
  • Private Clinics
  • Drug Stores
  • Hospitals
  • Retail Pharmacies
  • Others
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Questions Addressed by the Report
  • What are the Key Opportunities in Global Generic Drugs Market?
  • What will be the growth rate from 2019 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

Table of Contents

176 Pages
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Generic Drugs Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Generic Drugs Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Generic Drugs Market Share Analysis, By Product Type
5.3 Global Generic Drugs Market Size and Forecast, By Product Type
5.3.1 Simple Generics
5.3.2 Super Generics
5.3.3 Biosimilars
6 Global Generic Drugs Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Generic Drugs Market Share Analysis, By Application
6.3 Global Generic Drugs Market Size and Forecast, By Application
6.3.1 Anti-infective Drugs
6.3.2 Anti-Arthritis Drugs
6.3.3 Central Nervous System Drugs
6.3.4 Respiratory Products
6.3.5 Anti-Cancer Drugs
6.3.6 Others
7 Global Generic Drugs Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Generic Drugs Market Share Analysis, By Distribution Channel
7.3 Global Generic Drugs Market Size and Forecast, By Distribution Channel
7.3. 1 Pharmacies
7.3.2 Private Clinics
7.3.3 Drug Stores
7.3.4 Hospitals
7.3.5 Retail Pharmacies
7.3.6 Others
8 Global Generic Drugs Market, By Region
8.1 Global Generic Drugs Market Share Analysis, By Region
8.2 Global Generic Drugs Market Share Analysis, By Region
8.3 Global Generic Drugs Market Size and Forecast, By Region
9 North America Generic Drugs Market Analysis and Forecast (2020-2027)
9.1 Introduction
9.2 North America Generic Drugs Market Share Analysis, By Product Type
9.3 North America Generic Drugs Market Size and Forecast, By Application
9.4 North America Generic Drugs Market Size and Forecast, By Distribution Channel
9.5 North America Generic Drugs Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropeGeneric Drugs Market Analysis and Forecast (2020-2027)
10.1 Introduction
10.2 Europe Generic Drugs Market Share Analysis, By Product Type
10.3 Europe Generic Drugs Market Size and Forecast, By Application
10.4 Europe Generic Drugs Market Size and Forecast, By Distribution Channel
10.5 Europe Generic Drugs Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Generic Drugs Market Analysis and Forecast (2020-2027)
11.1 Introduction
11.2 Asia Pacific Generic Drugs Market Share Analysis, By Product Type
11.3 Asia Pacific Generic Drugs Market Size and Forecast, By Application
11.4 Asia Pacific Generic Drugs Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Generic Drugs Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Generic Drugs Market Analysis and Forecast (2020-2027)
12.1 Introduction
12.2 Latin America Generic Drugs Market Share Analysis, By Product Type
12.3 Latin America Generic Drugs Market Size and Forecast, By Application
12.4 Latin America Generic Drugs Market Size and Forecast, By Distribution Channel
12.5 Latin America Generic Drugs Market Size and Forecast, Country
13 Middle East Generic Drugs Market Analysis and Forecast (2020-2027)
13.1 Introduction
13.2 Middle East Generic Drugs Market Share Analysis, By Product Type
13.3 Middle East Generic Drugs Market Size and Forecast, By Application
13.4 Middle East Generic Drugs Market Size and Forecast, By Distribution Channel
13.5 Middle East Generic Drugs Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Abbott Laboratories
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. GlaxoSmithKline Plc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Eli Lilly and Company
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Pfizer Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 STADA Arzneimittel AG
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Teva Pharmaceutical
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Mylan N.V.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Sandoz International
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Baxter International
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 ALLERGAN
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us